Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Buloxibutid (AT2 receptor agonist C21) is a novel and selective small molecule angiotensin II AT2 receptor agonist with Ki values of 0.4 nM and 10 μM for AT2 and AT1 receptors, respectively.
説明 | Buloxibutid (AT2 receptor agonist C21) is a novel and selective small molecule angiotensin II AT2 receptor agonist with Ki values of 0.4 nM and 10 μM for AT2 and AT1 receptors, respectively. |
ターゲット&IC50 | AT1:>10 μM(ki), AT2:0.4 nM(ki) |
別名 | AT2 receptor agonist C21 |
分子量 | 475.62 |
分子式 | C23H29N3O4S2 |
CAS No. | 477775-14-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (47.31 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Buloxibutid 477775-14-7 Endocrinology/Hormones RAAS AT2 receptor agonist C21 Inhibitor inhibitor inhibit